• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORP, TAKAHAGI PLANT VISCO-3 25 MG/2.5 ML PFS (3/BOX) INJ; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORP, TAKAHAGI PLANT VISCO-3 25 MG/2.5 ML PFS (3/BOX) INJ; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Manufacturing, Packaging or Shipping Problem (2975)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/12/2018
Event Type  Injury  
Event Description
Only 1 syringe of the visco 3 was sent to (b)(6) office instead of 3 syringes - no missed doses, 2 syringes is reshipped to (b)(6) office.Dates of use: (b)(6) /2018 to present.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISCO-3 25 MG/2.5 ML PFS (3/BOX) INJ
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORP, TAKAHAGI PLANT
101 constitution ave nw
ste 900
washington DC 20001
MDR Report Key8019306
MDR Text Key125708944
Report NumberMW5080921
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier87541030131
UDI-Public87541030131
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 10/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/29/2018
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Age55 YR
-
-